Additionally, high or low arches can increase the risk of shin splints as the anterior tibialis must work harder to keep the foot from slapping the ground. 5 The non-human apes the gibbons, mountain and lowland gorillas, orang-utan, chimpanzee and bonobo tend to walk on the lateral side of the foot, that is with an ‘inverted’ foot, 6 which may reflect a basic adaptation to walking on branches. Blows to the foot that result in pain, discolouration, swelling, and changes in how you walk may indicate more serious damage. Commercial over-the-counter arch supports or orthotics may also help to ease arch pain. I love these. Place your thumb on the ball joint of the foot as shown in the photo to the right. Crosbie J. Pataky et alba New insights into the plantar pressure correlates of walking speed using pedobarographic statistical parametric mapping ppm, Journal of Biomechanics 41:1987 Pontzer et alba Locomotor anatomy and biomechanics of the Dmanisi hominids, Journal of Human Evolution 58:492. you can find out moreFoot Pain Self-Assessment Tool Forefoot Plantar Mid-Foot Plantar Heel Plantar Forefoot Dorsal Midfoot Dorsal The Pain on a scale of 1-10 is This tool is meant to help identify possible causes of pain. It continues to be a beloved d… Injury may present itself as a distinguishable lump, a gap felt at that location, or a “crunchy” feeling on that spot caused by inflammation. site link

This year, it features a 10-foot inflatable Santa, an 8-foot inflatable nutcracker-guarded welcome arch, light-up reindeer, a snowman and holiday castle, plus nine sets of lights and three projectors that reflect moving specs of lights on the walls. The Dominguez home is at 12754 SW 46th Lane. Nicks Starlight Spectacular For the sixth and final year, young Nick Caine is transforming his street in North Miami Beach into a big holiday festival . The college student has grown his home display at 1880 NE 181st St. into a Christmas block party with carnival rides, music, food and, of course, a bunch of lights. Caine uses the spectacular for charity, too. He raises money for the Make-A-Wish Foundation of Southern Florida. In past years, the event has raised enough money to help grant eight wishes for children with life-threatening medical conditions. This years event will run from 4:30-11 p.m. on Dec.

For the original version including any supplementary images or video, visit

( NEOS ) has submitted a New Drug Application to the FDA for its Amphetamine XR oral suspension drug candidate, NT-0201, for the treatment of attention-deficit hyperactivity disorder. NT-0201 is the company’s second extended-release amphetamine product candidate for the treatment of ADHD. The company’s first ADHD medication, Adzenys XR-ODTTM, was approved by the FDA in January and was launched in May 2016. NEOS closed Thursday’s trading at $8.75, up 5.42%. Regeneron Pharmaceuticals Inc.’s ( REGN ) phase III trial assessing the potential of Praluent to demonstrate cardiovascular benefit will continue as planned based on the recommendation of an independent Data Monitoring Committee. The trial, dubbed ODYSSEY OUTCOMES trial, involves more than 18,000 patients from 57 countries. Praluent, jointly developed by Sanofi and Regeneron, is an approved drug for the treatment of heterozygous familial hypercholesterolemia, or patients with atherosclerotic heart disease who require additional lowering of LDL-cholesterol. In the third quarter of 2016, global net sales of Praluent were $38 million compared to $4 million in the third quarter of 2015. REGN closed Thursday’s trading at $404.56, down 3.69%. ( SUPN ) fell more than 9% in extended trading on Thursday after being notified of non-compliance with the NASDAQ’s filing requirement. The company has failed to timely file its Quarterly Report on Form 10-Q for the period ended September 30, 2016.

For the original version including any supplementary images or video, visit

You may also be interested to read

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>